#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News in diabetology 2022


Authors: Milan Flekač
Authors‘ workplace: Diabetologické centrum VFN v Praze
Published in: Vnitř Lék 2023; 69(4): 270-273
Category: News in...
doi: https://doi.org/10.36290/vnl.2023.051

Overview

The use of new antidiabetic drugs in clinical practice in the last two decades has completely changed the Type 2 diabetes management. Following the results of new clinical trials, international recommendations for the treatment of diabetes were regularly modified. In the field of Type 1 diabetes, new technologies have appeared, such as smart insulin pens. We can await once weekly insulins and dual GLP-1 and GIP analogues in the near future.

Keywords:

SGLT2 inhibitors – heart failure – chronic kidney disease – GLP-1 RA – GIP – weekly insulin – diabetes management consensus


Sources

1. Melanie J, Davies J, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 1. November 2022; 45(11):2753–2786.

2. Paluch AE, et al. Daily steps and all‑cause mortality: a meta‑analysis of 15 international cohorts. Lancet Public Health. 2022;7(3):219–228.

3. Solomon SD, et al. DELIVER Trial Committees and Investigators. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022 Sep 22;387(12):1089-1098.

4. Herrington WG, et al. Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jan 12;388(2):117-127.

5. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216.

6. Bajaj HS, et al. Switching to Once‑Weekly Insulin Icodec Versus Once‑Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial. Diabetes Care. 2021 Jul;44(7):1586-1594. doi: 10.2337/dc20-2877.

7. Ekberg NR, et al. Smart pen exposes missed basal insulin injections and reveals the impact on glycemic control in adults with type 1 diabetes. J Diabetes Sci Technol. 2022 Jul 1.

Labels
Diabetology Endocrinology Internal medicine
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#